Today: 22 January 2026
Subscribe
Browse Category

Stocks News 20 December 2025 - 22 December 2025

Mastercard (MA) Stock: What to Know Before the Market Opens on December 22, 2025

Mastercard (MA) Stock: What to Know Before the Market Opens on December 22, 2025

U.S. markets reopen Monday, December 22, 2025, after the Friday, December 19 close—meaning investors are coming back from the weekend with a fresh batch of headlines around fees, litigation, buybacks, and product expansion that could shape sentiment in Mastercard Incorporated (NYSE: MA) early in the session. Mastercard shares last closed at $572.23 (with modest after-hours movement reported) as the market…
22 December 2025
····
Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson (NYSE: JNJ) heads into the U.S. market open on Monday, December 22, 2025, with investors balancing a familiar mix of defensive-healthcare appeal and headline-driven catalysts—from fresh talc litigation verdicts to FDA-related momentum in oncology and MedTech. Below is what matters most for JNJ stock right now, what analysts are projecting, and which near-term triggers could move shares…
22 December 2025
····
Micron Technology (MU) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Micron Technology (MU) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Micron Technology, Inc. (NASDAQ: MU) is entering the Dec. 22, 2025 session with fresh momentum after a blowout earnings report, a guidance outlook that reset expectations across the memory-chip industry, and a wave of analyst target increases. The bigger story isn’t just one strong quarter—it’s Micron’s message that the memory market (especially high-bandwidth memory, or HBM) is constrained enough that…
22 December 2025
····
PepsiCo Stock (NASDAQ: PEP) Week Ahead: Elliott-Driven Reset, Analyst Price Targets, and What to Watch (Dec. 22–26, 2025)

PepsiCo Stock (NASDAQ: PEP) Week Ahead: Elliott-Driven Reset, Analyst Price Targets, and What to Watch (Dec. 22–26, 2025)

PepsiCo, Inc. (NASDAQ: PEP) heads into the week of December 22–26, 2025 in a familiar spot for defensive consumer staples: the stock is reacting less to day-to-day hype and more to big-picture execution—pricing, product mix, productivity, and any headline risks that can quickly swing sentiment in a low-volume holiday market. As of December 21, 2025, PepsiCo shares are around $148.…
22 December 2025
····
Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) heads into the week of December 22–26, 2025 with a familiar setup for biotech investors: a cash-rich market leader in cystic fibrosis (CF), a pipeline that could meaningfully diversify revenue over the next 12–24 months, and a stock that can move quickly on headlines—even when broader markets are quiet. The difference this time is the…
22 December 2025
···
Philip Morris International (PM) Stock Week Ahead: Dividend Watch, FDA Nicotine Pouch Developments, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

Philip Morris International (PM) Stock Week Ahead: Dividend Watch, FDA Nicotine Pouch Developments, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

Published: Sunday, Dec. 21, 2025 (week-ahead outlook) Philip Morris International Inc. (NYSE: PM) heads into the Christmas-shortened trading week with a familiar mix of forces: a defensive consumer-staples profile, an income-driven shareholder base watching the next dividend milestone, and an evolving regulatory backdrop for nicotine pouches and other smoke-free products. PM shares last closed around $156.84 (Friday close), sitting well…
21 December 2025
····
Real Estate Stocks Week Ahead (Dec 22–26, 2025): REITs and Homebuilders Face Fed-Pause Signals, Mortgage-Rate Relief, and Holiday Liquidity

Real Estate Stocks Week Ahead (Dec 22–26, 2025): REITs and Homebuilders Face Fed-Pause Signals, Mortgage-Rate Relief, and Holiday Liquidity

As of Sunday, December 21, 2025, real estate stocks are heading into a holiday-shortened trading week with an unusually dense mix of cross-currents: easing mortgage rates, a Federal Reserve that just cut rates again but is now signaling patience, and thin year-end liquidity that can exaggerate daily moves. Reuters For investors tracking REITs, homebuilder stocks, and real estate ETFs, the…
21 December 2025
···
Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data center stocks head into the week of December 22, 2025 at an unusual intersection: the AI infrastructure buildout is still accelerating, but markets are getting far less forgiving about how it’s funded, how quickly it pays back, and whether the power grid can keep up. That tension was on full display from December 19–21—a three-day stretch that brought fresh…
21 December 2025
··
Rivian Stock (RIVN) in Focus: AI Autonomy Push, R2 Countdown, and Fresh Analyst Targets (Dec. 21, 2025)

Rivian Stock (RIVN) in Focus: AI Autonomy Push, R2 Countdown, and Fresh Analyst Targets (Dec. 21, 2025)

Rivian Automotive, Inc. (NASDAQ: RIVN) is heading into the final stretch of 2025 with a very different story than it started the year with. Yes, it’s still the maker of the adventure-flavored R1T pickup and R1S SUV—but this week, Rivian stock moved like a company trying to be valued as a software-and-silicon platform, not just an EV manufacturer. Because today…
21 December 2025
····
Rolls-Royce Holdings Stock (RR.L) Forecast & News: £200m Buyback, Defence Momentum and the 2026 Outlook

Rolls-Royce Holdings Stock (RR.L) Forecast & News: £200m Buyback, Defence Momentum and the 2026 Outlook

December 21, 2025 — Rolls-Royce Holdings plc shares (LSE: RR., ADR: RYCEY) are ending 2025 with momentum again, helped by a fresh capital return plan and a steady drip of operational and contract updates across Civil Aerospace, Defence and Power Systems. The stock closed at £11.70 (1,170p) on Friday, December 19, leaving it just a touch below its 52‑week high…
21 December 2025
····
Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings Inc. (NASDAQ: ONDS) is ending the week in the spotlight after a sharp rally that pushed the stock to a $9.22 close on Friday, Dec. 19, up 18.21% in a single session on heavy volume. The move caps off a volatile stretch in which Ondas has been issuing a fast cadence of defense-and-autonomy updates—while also filing capital-structure disclosures…
21 December 2025
····
Moderna Stock (MRNA) News, Forecasts and Analysis: CEPI Bird Flu Funding, FDA Scrutiny and the 2026 Outlook (Dec. 20, 2025)

Moderna Stock (MRNA) News, Forecasts and Analysis: CEPI Bird Flu Funding, FDA Scrutiny and the 2026 Outlook (Dec. 20, 2025)

December 20, 2025 — Moderna, Inc. (NASDAQ: MRNA) is ending the year in classic Moderna fashion: a tug-of-war between near-term uncertainty (COVID policy and demand) and long-term optionality (a pipeline that still wants to be the sequel to the pandemic-era blockbuster). The stock last traded around $33.80, up roughly 9% from the prior close, with a market cap near $13…
20 December 2025
····
1 … 40 41 42 43 44 … 90

Stock Market Today

  • Microequities Asset Management Group (ASX:MAM) Posts 0.9% Total Shareholder Return over Three Years
    January 22, 2026, 5:47 PM EST. Microequities Asset Management Group's (ASX:MAM) share price dropped 16% over the past three years, underperforming the market's approximate 30% gain. The company's earnings per share (EPS) declined about 20% annually, yet the market maintains a degree of optimism. Including dividends, the total shareholder return (TSR) modestly improved to 0.9% for the period, highlighting the role of dividends in offsetting price losses. TSR in the last 12 months reached 9.5%, and 11% annually over five years. Investors should weigh these returns against identified investment risks flagged for MAM, making comprehensive risk assessment essential before investing.
Go toTop